Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jin Medical International (ZJYL) Inventory (2022 - 2025)

Jin Medical International (ZJYL) has disclosed Inventory for 4 consecutive years, with $4.9 million as the latest value for Q3 2025.

  • Quarterly Inventory fell 4.84% to $4.9 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $4.9 million through Sep 2025, down 4.84% year-over-year, with the annual reading at $4.9 million for FY2025, 4.84% down from the prior year.
  • Inventory hit $4.9 million in Q3 2025 for Jin Medical International, down from $5.2 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $6.7 million in Q3 2022 to a low of $803745.0 in Q3 2023.
  • Historically, Inventory has averaged $4.4 million across 4 years, with a median of $5.0 million in 2024.
  • Biggest five-year swings in Inventory: crashed 88.05% in 2023 and later soared 543.67% in 2024.
  • Year by year, Inventory stood at $6.7 million in 2022, then plummeted by 88.05% to $803745.0 in 2023, then skyrocketed by 543.67% to $5.2 million in 2024, then decreased by 4.84% to $4.9 million in 2025.
  • Business Quant data shows Inventory for ZJYL at $4.9 million in Q3 2025, $5.2 million in Q3 2024, and $803745.0 in Q3 2023.